Editorial: Small molecule inhibitors targeting mammalian selenoprotein thioredoxin reductases (TXNRDs): Interactions, mechanisms, and applications

Front Mol Biosci. 2023 Feb 2:10:1141772. doi: 10.3389/fmolb.2023.1141772. eCollection 2023.

Authors

Jianqiang Xu¹, Alexios Vlamis-Gardikas², Jianguo Fang³

Affiliations

¹ School of Life and Pharmaceutical Sciences (LPS) and Panjin Institute of Industrial Technology (PIIT), Dalian University of Technology, Panjin, China.
² Department of Chemistry, University of Patras, Rion, Greece.
³ State Key Laboratory of Applied Organic Chemistry & College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, China.

No abstract available

Keywords: cancer therapy; inhibitor; reactive oxygen species; redox regulation; selenoprotein; small molecule; thioredoxin reductase.

Publication types

Editorial